Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Platelex is a biotechnology company specializing in the development and commercialization of autologous platelet-derived therapies and regenerative medicine products. The company's flagship technology, Platelex-ACT, is a platelet-rich plasma (PRP) and platelet gel system used to accelerate tissue repair and manage surgical bleeding by delivering a concentrated dose of growth factors directly to injury sites. Platelex products are widely utilized in orthopedic surgery, sports medicine, and chronic wound management to stimulate the body's natural healing processes. By providing standardized kits for the preparation of autologous conditioned plasma, the company addresses critical needs in hemostasis and regenerative therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Platelex.